You are here: Industry Insights > Purdue

News List

After Oklahoma payout, Purdue faces 5 new state lawsuits over OxyContin fiercepharma
May 21, 2019
Purdue Pharma and its founding family took a quarter-of-a-billion-dollar hit when it settled with the state of Oklahoma over a lawsuit accusing the company of pushing false and misleading ads for powerful opioid OxyContin.
Purdue agrees to pay $270 million to Oklahoma to resolve OxyContin lawsuit firstwordpharma
March 27, 2019
Purdue Pharma agreed on Tuesday to pay about $270 million to Oklahoma to resolve allegations that the drugmaker fuelled the opioid crisis through its aggressive marketing of OxyContin (oxycodone).
Sackler family directed—and covered up—Purdue's opioid sales tactics. Now, it should pay the price: AG fiercepharma
January 17, 2019
Purdue Pharma has faced years of investigations and legal proceedings over its marketing for OxyContin. Now, Massachusetts Attorney General Maura Healey has filed an amended complaint laying out a detailed account of the alleged role the company's foundin
Sackler family directed—and covered up—Purdue's opioid sales tactics. Now, it should pay the price: AG fiercepharma
January 17, 2019
Purdue Pharma has faced years of investigations and legal proceedings over its marketing for OxyContin. Now, Massachusetts Attorney General Maura Healey has filed an amended complaint laying out a detailed account of the alleged role the company's foundin
Purdue defends against opioid lawsuits by pointing to FDA regulations it helped create fiercepharma
July 17, 2018
Purdue is defending itself against lawsuits around the country alleging it downplayed opioid risks and overstated their benefits.
Shionogi Regains Full Rights to Symproic (naldemedine) in the US firstwordpharma
July 10, 2018
OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE)-- Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") has announced that effective immediately
Purdue culls 350 positions, eradicates sales force pharmafile
June 22, 2018
Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue Pharma has announced that it has axed around 350 employees from the company, a move which also includes the eradication of the remainder of i
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant fiercebiotech
June 11, 2018
Eisai and Purdue Pharma have presented new clinical trial results of their dual orexin receptor antagonist lemborexant, which they think could become a new force in the sleep disorder market.
Road Map to modernized production of lifesaving drugs, food preservation identified by Purdue Univer biospectrumasia
September 14, 2017
The LyoHUB has 14 industry members, including pharmaceutical companies and equipment manufacturers

Previous page 1 2 Next page